FindTrial
Sign In

Spectral CT imaging of pancreatic cancer

Spectral CT imaging of pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100415
Enrollment
Unknown
Registered
2025-04-09
Start date
2023-08-03
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

Gold Standard:Pathology
Index test:Monoenergetic image, iodine density map, atomic number map, electron density map of spectral CT

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. clinically diagnosed as the first episode of pancreatic cancer; 2,no intra-abdominal or retroperitoneal tumors; 3.planned radical resection of pancreatic cancer.

Exclusion criteria

Exclusion criteria: 1,Poor CT image quality or inability to perform multi-dimensional post-processing; 2. CT before treatment and treatment time more than 1 month; 3. pancreatic cancer was excluded by postoperative pathology; 4. No signs of vascular invasion were found in preoperative images.

Design outcomes

Primary

MeasureTime frame
Spectral CT;prognosis;—

Secondary

MeasureTime frame
pathology results;—

Countries

China

Contacts

Public ContactZixing Huang

West China Hospital, Sichuan University

zixinghuang@hotmail.com+86 138 8220 6874

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026